The Institutional Biosafety Committee is charged with reviewing all registrations for research, teaching, and training that involve the use of recombinant DNA and Synthetic Nucleic Acid Molecules (rDNA) at Georgia Tech and for ensuring that the proposed activities comply with the federal regulations and institute policies governing these activities.
The Institutional Biosafety Committee is constituted in accordance with the National Institutes of Health Guidelines for Research involving Recombinant or Synthetic Nucleic Acid Molecules-Revised March 2013; members are appointed by the Executive Vice President for Research. The Institutional Biosafety Committee generally meets monthly, and as needed to review registrations proposing use of recombinant DNA.
The Office of Research Integrity Assurance provides administrative support to the committee and is responsible for maintaining Georgia Tech’s registration with the National Institutes of Health’s Office of Biotechnology Activities (OBA).
The following prerequisites are required for IBC Protocol Approval
- All individuals listed on the application (including the PI) must be up-to-date with all required trainings.
- All individuals listed on the application (including the PI) must be enrolled in the Biosafety Occupational Health Program.
- A successful biosafety lab inspection completed within the past year.
- PI must submit a current Biological Hygiene Plan along with their registration.